Becton Dickinson and Co
NYSE:BDX
Relative Value
The Relative Value of one BDX stock under the Base Case scenario is 365.93 USD. Compared to the current market price of 240.35 USD, Becton Dickinson and Co is Undervalued by 34%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
BDX Competitors Multiples
Becton Dickinson and Co Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Becton Dickinson and Co
NYSE:BDX
|
69.4B USD | 3.6 | 57 | 19 | 40.2 | ||
US |
Abbott Laboratories
NYSE:ABT
|
183.7B USD | 4.6 | 32.6 | 19.2 | 28.6 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
134B USD | 18.3 | 67.4 | 55.3 | 69.3 | ||
US |
Stryker Corp
NYSE:SYK
|
124.3B USD | 5.9 | 37 | 24 | 29.6 | ||
IE |
Medtronic PLC
NYSE:MDT
|
107.6B USD | 3.3 | 25.6 | 13.6 | 19.3 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 7.2 | 59.8 | 30.5 | 45 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
57.7B EUR | 2.6 | 38 | 18.3 | 30.8 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.2B USD | 8.3 | 36.2 | 26.3 | 28.5 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
50.2B USD | 13.2 | 78.5 | 58.6 | 76.4 | ||
US |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
39.5B USD | 10.8 | 46.8 | 32.9 | 36.4 |